Trial NCT01301612

View at ClinicalTrials.gov 
Org. Study IDs: EF 110

Last trial update was posted on 2014-07-14

MeSH Interventions

Cisplatin Nimotuzumab

MeSH Conditions

Adenocarcinoma Carcinoma Carcinoma, Adenosquamous

Other Conditions

Uterine Cervix Adenosquamous Carcinoma

Stopping Reasons

Regulatory requirement. A phase III study is being designed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID